Regulation of DNA supercoiling in Escherichia coli: genetic basis of a compensatory mutation in DNA gyraseMCEACHERN, F; FISHER, L. M.FEBS letters. 1989, Vol 253, Num 1-2, pp 67-70, issn 0014-5793, 4 p.Article

The role of topoisomerases in cell differentiation: abstracts/Leukemia Society of America, focused workshop, May 15, 1987, Boston, MA, USALeukemia. 1987, Vol 1, Num 12, pp 825-828, issn 0887-6924Conference Proceedings

Mechanistic aspects of DNA topoisomerasesMAXWELL, A; GELLERT, M.Advances in protein chemistry. 1986, Vol 38, pp 69-107, issn 0065-3233Article

Topoisomerase inhibitors : a review of their therapeutic potential in cancerSINHA, B. K.Drugs (Basel). 1995, Vol 49, Num 1, pp 11-19, issn 0012-6667Article

Les poisons des ADN topo-isomérases de type I et II = Poisons of type I and II DNA topoisomerasesCHARCOSSET, J. Y; SOUES, S; LAVAL, F et al.Bulletin du cancer. 1993, Vol 80, Num 11, pp 923-954, issn 0007-4551Article

DNA topoisomerases and models of sister-chromatid exchangeDILLEHAY, L. E; JACOBSON-KRAM, D; WILLIAMS, J. R et al.Mutation research. 1989, Vol 215, Num 1, pp 15-23, issn 0027-5107Article

Recent studies of DNA topoisomerasesWANG, J. C.Biochimica et biophysica acta. 1987, Vol 909, Num 1, pp 1-9, issn 0006-3002Article

DNA topoisomerase I and II in cancer chemotherapy : update and perspectivesPOMMIER, Y.Cancer chemotherapy and pharmacology. 1993, Vol 32, Num 2, pp 103-108, issn 0344-5704Conference Paper

Topoisomerases, new targets in cancer chemotherapy (review)ZIJLSTRA, J. G; DE JONG, S; DE VRIES, E. G. E et al.Medical oncology and tumor pharmacotherapy. 1990, Vol 7, Num 1, pp 11-18, issn 0736-0118, 8 p.Article

Effect of phenazine compounds XR11576 and XR5944 on DNA topoisomerasesJOBSON, Andrew G; WILLMORE, Elaine; TILBY, Michael J et al.Cancer chemotherapy and pharmacology. 2009, Vol 63, Num 5, pp 889-901, issn 0344-5704, 13 p.Article

Differential expression of DNA topoisomerases I and II during the eukaryotic cell cycleHECK, M. M. S; HITTELMAN, W. N; EARNSHAW, W. C et al.Proceedings of the National Academy of Sciences of the United States of America. 1988, Vol 85, Num 4, pp 1086-1090, issn 0027-8424Article

The current status of camptothecin analogues as antitumor agentsSLICHENMYER, W. J; ROWINSKY, E. K; DONEHOWER, R. C et al.Journal of the National Cancer Institute. 1993, Vol 85, Num 4, pp 271-291, issn 0027-8874Article

Depletion of topoisomerase II in isolated nuclei during a glucose-regulated stress responseJUN-WEN SHEN; SUBJECK, J. R; LOCK, R. B et al.Molecular and cellular biology (Print). 1989, Vol 9, Num 8, pp 3284-3291, issn 0270-7306, 8 p.Article

Human DNA topoisomerase I is encoded by a single-copy gene that maps to chromosome region 20q12-13.2CHUNG-CHING JUAN; HWANG, J; LIU, A. A et al.Proceedings of the National Academy of Sciences of the United States of America. 1988, Vol 85, Num 23, pp 8910-8913, issn 0027-8424Article

Cullin 3 promotes proteasomal degradation of the topoisomerase I-DNA covalent complexZHANG, Hua-Feng; TOMIDA, Akihiro; KOSHIMIZU, Ritsuko et al.Cancer research (Baltimore). 2004, Vol 64, Num 3, pp 1114-1121, issn 0008-5472, 8 p.Article

Lamellarin D: A novel potent inhibitor of topoisomerase IFACOMPRE, Michaël; TARDY, Christelle; BAL-MAHIEU, Christine et al.Cancer research (Baltimore). 2003, Vol 63, Num 21, pp 7392-7399, issn 0008-5472, 8 p.Article

Werner protein stimulates topoisomerase I DNA relaxation activityLAINE, Jean-Philippe; OPRESKO, Patricia L; INDIG, Fred E et al.Cancer research (Baltimore). 2003, Vol 63, Num 21, pp 7136-7146, issn 0008-5472, 11 p.Article

Tracking enzymatic steps of DNA topoisomerases using single-molecule micromanipulationSTRICK, Terence R; CHARVIN, Gilles; DEKKER, Nynke H et al.Comptes rendus. Physique. 2002, Vol 3, Num 5, pp 595-618, issn 1631-0705Article

DNA topoisomerase V is a relative of eukaryotic topoisomerase I from a hyperthermophilic prokaryoteSLESAREV, A. I; STETTER, K. O; LAKE, J. A et al.Nature (London). 1993, Vol 364, Num 6439, pp 735-737, issn 0028-0836Article

Mechanism of action of and resistance to quinolonesBEARDEN, David T; DANZIGER, Larry H.Pharmacotherapy. 2001, Vol 21, Num 10, pp 224S-232S, issn 0277-0008, 2Article

Exploiting bacterial DNA gyrase as a drug target: current state and perspectivesCOLLIN, Frédéric; KARKARE, Shantanu; MAXWELL, Anthony et al.Applied microbiology and biotechnology. 2011, Vol 92, Num 3, pp 479-497, issn 0175-7598, 19 p.Article

The nature of DNA plays a role in chromosome segregation: endoreduplication in halogen-substituted chromosomesCORTES, Felipe; PASTOR, Nuria; MATEOS, Santiago et al.DNA repair. 2003, Vol 2, Num 6, pp 719-726, issn 1568-7864, 8 p.Article

ENZYMES AFFECTING THE GROSS MORPHOLOGY OF DNA. I: TOPOISOMERASES TYPE 1. II: TOPOISOMERASES TYPE 21983; METHODS IN ENZYMOLOGY; ISSN 0076-6879; USA; DA. 1983; VOL. 100; PP. 131-180; BIBL. DISSEM.Article

Both DNA topoisomerases I and II relax 2 μm plasmid DNA in living yeast cellsSAAVEDRA, R. A; HUBERMAN, J. A.Cell (Cambridge). 1986, Vol 45, Num 1, pp 65-70, issn 0092-8674Article

Inhibition of DNA topoisomerases I and II, and growth inhibition of human cancer cell lines by a marine microalgal polysaccharideUMEMURA, Ken; YANASE, Kae; SUZUKI, Mitsue et al.Biochemical pharmacology. 2003, Vol 66, Num 3, pp 481-487, issn 0006-2952, 7 p.Article